Corbus Pharmaceuticals Holdings (CRBP) Other Working Capital Changes (2015 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) posted quarterly Other Working Capital Changes of -$407000.0 for Q3 2025, down 11.51% year-over-year from -$459922.6 in Q3 2024, and down 2.01% quarter-over-quarter from -$399000.0 in Q2 2025.
Corbus Pharmaceuticals Holdings (CRBP) Other Working Capital Changes (2015 - 2025) Analysis & Trends
Corbus Pharmaceuticals Holdings' Other Working Capital Changes history runs 2 years deep, the most recent figure standing at -$29.5 million for Q2 2019.
- In Q3 2025, Other Working Capital Changes fell 11.51% year-over-year to -$407000.0; the TTM figure through Sep 2025 stood at -$1.6 million (down 11.66% YoY), while the FY2024 annual figure was -$1.4 million, down 12.18% from the prior year.
- Other Working Capital Changes for Q2 2019 stood at -$29.5 million, down from $25.5 million in the prior quarter.
- The five-year high for Other Working Capital Changes was -$237592.0 in Q1 2021, with the low at -$731267.0 in Q4 2022.
- The 5-year median for Other Working Capital Changes is -$325000.0 (2023), against an average of -$341339.8.
- The sharpest annual moves came in 2021 and 2022: Other Working Capital Changes soared 94.6% in 2021, then tumbled 180.61% in 2022.
- Corbus Pharmaceuticals Holdings' Other Working Capital Changes stood at -$260600.0 in 2021, then sank by 180.61% to -$731267.0 in 2022, then soared by 54.6% to -$332000.0 in 2023, then decreased by 11.75% to -$371000.0 in 2024, then decreased by 9.7% to -$407000.0 in 2025.
- Business Quant data shows CRBP's Other Working Capital Changes at -$29.5 million in Q2 2019, $25.5 million in Q1 2019, and $1292.0 in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Corbus Pharmaceuticals Holdings | 121.72 Mn | -41.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -407,000.00 |
| Sep 30, 2025 | -407,000.00 |
| Sep 30, 2025 | -407,000.00 |
| Jun 30, 2025 | -399,000.00 |
| Jun 30, 2025 | -399,000.00 |
| Jun 30, 2025 | -399,000.00 |
| Mar 31, 2025 | -384,000.00 |
| Mar 31, 2025 | -384,000.00 |
| Mar 31, 2025 | -384,000.00 |
| Dec 31, 2024 | -371,000.00 |
| Dec 31, 2024 | -371,000.00 |
| Dec 31, 2024 | -371,000.00 |
| Sep 30, 2024 | -365,000.00 |
| Sep 30, 2024 | -365,000.00 |
| Sep 30, 2024 | -365,000.00 |
| Jun 30, 2024 | -358,000.00 |
| Jun 30, 2024 | -358,000.00 |
| Jun 30, 2024 | -358,000.00 |
| Mar 31, 2024 | -343,000.00 |
| Mar 31, 2024 | -343,000.00 |